COVID-19 Pediatric Vaccine for Children ages 5-11
On October 29th, 2021, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to the Pfizer-BioNTech COVID-19 vaccine for children ages 5 through 11 years old. This authorization was based on robust safety and efficacy data of the vaccine in children. The results from pediatric studies demonstrate: 7% effectiveness in those …
COVID-19 Pediatric Vaccine for Children ages 5-11 Read More »